Dr. Stuart Goldberg weighs in on historic FDA approval of blockbuster leukemnia drug

August 31, 2017

Stuart Goldberg, M.D., an oncologist at the John Theurer Cancer Center and chief medical officer of Cota, weighs in on how advances in cancer care should be balanced against the need to get health care costs under control.

Read full article on forbes.com.